SPR@1
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Learn from Your Mistakes: Tree-like Self-Play for Secure Code LLMs
arXiv:2606.03489v1 Announce Type: new Abstract: While Large Language Models (LLMs) excel in code generation, they remain prone to replicating subtle yet critical vulnerabilities endemic to their training data. Current alignment techniques, such as Supervised Fine-Tuning (SFT) and Reinforcement Learning (RL), typically apply coarse-grained optimization at the sequence level. This approach often fails to address the localized nature of security flaws, where a single incorrect token choice can...
Listen up, England. The Health Secretary is going to be data controller for everyone's Single Patient Record
Health secretary James Murray has said that he will become a data controller of all National Health Service records in England shared through the government’s planned single patient record (SPR). Murray, who is formally the secretary of state for health, told the House of Commons on 1 June that GP surgeries, NHS trusts and other care providers will continue to manage and take responsibility for their own records, but added: “Where that information is then shared through the single patient...
Why China is buying less Iranian oil - explained in charts
The Strait of Hormuz, just 29 nautical miles (54 km) wide at narrowest point may be one of the world's most critical oil chokepoints. But as disruptions rattles the waterway, an unexpected trend is emerging, as China which is Iran's biggest oil customer is buying significantly less crude. While Beijing continues to rely on Tehran for discounted oil, weaker domestic demand, refinery cutbacks, record stockpiles and the rapid rise of electric vehicles have reduced its need for fresh imports.
Molecular glue degraders of HuR suppress BRAF-mutant colorectal cancer
Abstract BRAF gain-of-function mutations, particularly BRAF(V600E), affect roughly 10% of all patients with colorectal cancer (CRC), and portend poor prognosis with limited therapeutic interventions. BRAF inhibitors such as encorafenib are ineffective due to MAPK pathway reactivation driven by BRAF dimerization. Combined inhibition of BRAF and EGFR, although approved therapies, results in short survival benefits and frequent treatment resistance and relapse1,2,3.
Sort, Partition, Randomize: Optimal Binary Hypothesis Testing under Local Differential Privacy
Announce Type: new Abstract: We study optimal design of $\varepsilon$-locally differentially private mechanisms for binary hypothesis testing. Each observation is drawn from one of two known distributions $P_0,P_1$ on a finite alphabet of size $k$, privatized by a mechanism $Q$, and then used to infer which distribution generated the data. We measure testing utility using an $f$-divergence, including total variation, KL, and hockey-stick divergences, between the two induced output distributions.